Found 0 matching trials
Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer PHASE4 The clinical trial concerns the use of an innovative \"anti-emetic\"...
Show More Location
ASST Spedali Civili di Brescia
Learn More & Join Trial
A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer PHASE3 Multicenter, randomized, double-blind, double-dummy, parallel group, strati...
Show More Location
The Oncology Inst. Of Hope and Innovation
Learn More & Join Trial
PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and Vomiting PHASE2 This study is Phase 2 pharmacokinetic (PK) and pharmacodynamic (PD) dose-fi...
Show More Location
Nemours/A.I. duPont Hospital for Children
Learn More & Join Trial
A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting PHASE3 NEPA-15-18 is a clinical study assessing safety of pro-netupitant and palon...
Show More Location
Sarcoma Oncology Center
Learn More & Join Trial
Bioequivalence and Safety Study of IN-A012 and Akynzeo Capsules in Male and Female Healthy Korean Subjects PHASE1 The main purpose of this study is to demonstrate the bioequivalence between...
Show More Location
Catholic Univ. of Seoul St. Mary's Hospital
Learn More & Join Trial
Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer PHASE3 This study aims to elucidate the therapeutic efficacy of electroacupuncture...
Show More Location
Qinghai University Affiliated Hospital
Learn More & Join Trial
Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer PHASE3 This randomized controlled phase III trial aims to evaluate the use of elec...
Show More Location
Qinghai University Affiliated Hospital
Learn More & Join Trial
Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer PHASE2 This is a longitudinal, one arm, prospective phase II study, designed to ev...
Show More Learn More & Join Trial
Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer PHASE3 This randomized phase III trial studies how well netupitant/palonosetron hy...
Show More Learn More & Join Trial